SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 77 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504,400 | -54.8% | 1,323,885 | -1.6% | 0.06% | -42.9% |
| Q2 2023 | $1,116,949 | -31.4% | 1,345,722 | 0.0% | 0.10% | -26.9% |
| Q1 2023 | $1,628,324 | -39.8% | 1,345,722 | 0.0% | 0.13% | -36.2% |
| Q4 2022 | $2,704,901 | -19.6% | 1,345,722 | 0.0% | 0.21% | -5.0% |
| Q3 2022 | $3,364,000 | +1.7% | 1,345,722 | +55.4% | 0.22% | -21.1% |
| Q2 2022 | $3,307,000 | -63.7% | 865,722 | -40.0% | 0.28% | -31.4% |
| Q1 2022 | $9,105,000 | -45.4% | 1,442,870 | 0.0% | 0.41% | -13.2% |
| Q4 2021 | $16,680,000 | -44.6% | 1,442,870 | -46.4% | 0.47% | -37.3% |
| Q3 2021 | $30,133,000 | -59.3% | 2,692,870 | 0.0% | 0.75% | -60.1% |
| Q2 2021 | $74,000,000 | – | 2,692,870 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Revelation Capital Management, LLC | 2,219,951 | $14,008,000 | 51.22% |
| ARCH Venture Management, LLC | 3,798,926 | $23,971,000 | 3.43% |
| Tikvah Management LLC | 707,600 | $4,465,000 | 1.43% |
| Triatomic Management LP | 221,708 | $1,399,000 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,612,019 | $41,722,000 | 0.93% |
| Perceptive Advisors | 3,655,207 | $23,064,000 | 0.46% |
| Casdin Capital, LLC | 1,442,870 | $9,105,000 | 0.41% |
| Orbimed Advisors | 2,300,792 | $14,518,000 | 0.24% |
| Nicholas Investment Partners, LP | 519,885 | $3,280,000 | 0.23% |
| Alphabet Inc. | 586,584 | $3,701,000 | 0.12% |